The news at ISIS is getting better every day. Financials will take a major improvemnet in Q1 and have enabled ISIS to partner or go it alone on a future drug. Milestones are in sight on several Phase III drugs.
Best Of |
Favorites & Replies |
Start a New Board |
My Fool |
BATS data provided in real-time. NYSE, NASDAQ and NYSEMKT data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates, Analyst Rat